REPORT HIGHLIGHT

The U.S neurorehabilitation service market was valued at USD 20.6 billion by 2019, growing with 4.1% CAGR during the forecast period, 2021-2027.

Neurorehabilitation is a technique for patients suffering from any disease, disorder of the nervous system, or injury. This technique tends to improve the condition of patients by reducing the symptoms and thereby, improves the quality of life of the patients.  Neurorehabilitation therapy is mostly done after the treatment of brain injury to help in the recovery of the patient and maximize their cognitive and functional abilities. The U.S. neurorehabilitation service market is projected to cross the revenue of ~US$ 28 Billion by the end of 2027.

Market Dynamics

The rehabilitation industry has evolved at a rapid pace over the past few years driven by advancements in technologies coupled with ongoing COVID-19 pandemic. Following the same trend, neurorehabilitation has gradually changed in the past couple of years. Traditionally neurorehabilitation therapy offered limited ability in patients with mutual neurological illnesses, such as Parkinson’s disease, stroke, spinal cord injury, brain injury, and cognitive disorders. Innovative technologies have enhanced the efficiency of rehabilitation approaches in these conditions. The new technology in the neurorehabilitation includes virtual reality, functional electro-stimulation, non-invasive brain stimulation (NIBS) to improve the strength and superiority of such services.

Many vendors in this market are focused on increasing their efforts to fulfill the rising demand through strengthening their product offerings. For example, a Massachusetts based healthcare company, BIONIK offers innovative robotic tools such as InMotionRobots, InMotionARM, and InMotion Connect for neurorehabilitation professionals. In addition, the U.S. based exoskeleton bionic devices firm, Ekso Bionics Holdings Inc. awarded a contract to develop a next-generation exoskeleton design for the DARPA’s (Defense Advanced Research Projects Agency) Warrior Web program. The aforementioned factors are supporting the U.S neurorehabilitation service market growth. However, low product awareness in developing regions coupled with high cost will create a significant gap in the fulfillment of market expectations.

Indication Takeaway

In terms of indication, the U.S neurorehabilitation service market is broadly categorized into traumatic brain injury, stroke, and spinal cord injury. Among these, the stroke category accounted for the maximum revenue share as the stroke cases increasing consistently. As per the World Health Organization (WHO), more than 15 million people suffer from stroke conditions worldwide every year. Increasing blood pressure cases is also a key contributing factor for this segment’s growth. On the contrary, the traumatic brain injury segment is projected to grow with promising CAGR over the study period

Service Type Takeaway

On the basis of service type, the industry is divided into inpatient and outpatient services. Of these, the outpatient service posted a significant revenue share in 2019. The outpatient neurorehabilitation program consists of a comprehensive team of specialists who are dedicated to providing the highest level of service and care through a trans-disciplinary, collaborative approach. The areas of expertise that outpatient therapy covers include stroke, brain injury, concussion, Parkinson’s disease, and complex neurological conditions. Companies are coming up with new programs that staffed with a line-up of neurologists trained in neuro-physical therapy, speech therapy, neuropsychology, clinical counseling, and occupational therapy,

COVID-19 Impact

The emergence of the life-threatening COVID-19 has brought the world to a halt affecting approximately half of the population globally. The rehabilitation industry is expected to grow at a significant rate during the pandemic period as it improves the health of patients with severe cases of COVID-19 and benefits health services by reducing complications associated with an ICU.

Moreover, it also helps and ensures patients do not require readmission, post-treatment is a critical factor for the shortage of beds in the hospitals. In addition, there is an extensive and ever-increasing need for rehabilitation internationally which is principally insightful in low and middle-income countries. Thereby, WHO/Europe is developing guidance to support and advise rehabilitation professionals throughout the pandemic.

Key Vendor Takeaway

The leading players of the U.S neurorehabilitation service market include Rehabtronics, St. Jude Medical, Medtronic, Ekso Bionics, MagVenture A/S, Bioxtreme, Helius Medical, Neuro Style, and Hocoma. This proposed report analyzes the current market stand and future growth prospects of these players.

Key players are striving to bring advanced and innovative products through strategic collaborations due to the gradual increase in demand for neurorehabilitation services. For instance, in September 2019, U.S. based medical device company, Helius Medical Technologies, Inc. collaborated with the neuroscience firm, HealthTech Connex. They have announced the opening of Apollo Physical Therapy Centre (Apollo), featuring the non-invasive Portable Neuromodulation Stimulator (PoNS) device. Likewise in July 2017, the NBETTER Stroke Rehabilitation System launched new neuro-style brain exercise therapy. The new therapy uses EEG and a brain-computer interface (BFI) to improve the recovery of disabled chronic and sub-acute stroke patients.

The market size and forecast for each segment and sub-segments has been considered as below:

• Historical Year – 2015 to2018
• Base Year – 2019
• Estimated Year – 2020
• Projected Year – 2026

TARGET AUDIENCE

• Traders, Distributors, and Suppliers
• Manufacturers
• Government and Regional Agencies
• Research Organizations
• Consultants
• Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

U.S. NEUROREHABILITATION SERVICES MARKET KEY PLAYERS

• Jude Medical
• Medtronic plc
• Ekso Bionics Holdings Inc.
• BIONIK
• Rehabtronics
• MagVenture A/S
• BioXtreme
• Helius Medical
• Neurostyle Pte Ltd
• Hocoma, Inc.

U.S. NEUROREHABILITATION SERVICES MARKET, BY INDICATION

• Traumatic Brain Injury(TBI)
• Stroke
• Spinal Cord Injury (SCI)
• Others

U.S. NEUROREHABILITATION SERVICES MARKET, BY SERVICE TYPE

• Inpatient
• Outpatient